{"id":"https://openalex.org/W2552764468","doi":"https://doi.org/10.1182/blood.v126.23.3670.3670","title":"A Novel, Oncogenic CSF2RB Mutation Found in a Primary Leukemia Sample Results in Constitutive Signaling, Increased Receptor Stability, and Formation of Intermolecular Complexes","display_name":"A Novel, Oncogenic CSF2RB Mutation Found in a Primary Leukemia Sample Results in Constitutive Signaling, Increased Receptor Stability, and Formation of Intermolecular Complexes","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2552764468","doi":"https://doi.org/10.1182/blood.v126.23.3670.3670","mag":"2552764468"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.3670.3670","doi":"https://doi.org/10.1182/blood.v126.23.3670.3670","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.3670.3670","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081773810","display_name":"Kevin Watanabe\u2010Smith","orcid":"https://orcid.org/0000-0003-4231-8562","observed_orcids":["https://orcid.org/0000-0003-4231-8562"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin M Watanabe-Smith","raw_affiliation_strings":["Oregon Health and Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health and Science University, Portland, OR","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014545118","display_name":"Cristina E. Tognon","orcid":"https://orcid.org/0000-0002-4872-3078","observed_orcids":["https://orcid.org/0000-0002-4872-3078"]},"institutions":[{"id":"https://openalex.org/I1344073410","display_name":"Howard Hughes Medical Institute","ror":"https://ror.org/006w34k90","country_code":"US","type":"facility","lineage":["https://openalex.org/I1344073410"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Cristina E. Tognon","raw_affiliation_strings":["Howard Hughes Medical Institute, Portland, OR","Knight Cancer Institute, Oregon Health and Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Howard Hughes Medical Institute, Portland, OR","institution_ids":["https://openalex.org/I1344073410"]},{"raw_affiliation_string":"Knight Cancer Institute, Oregon Health and Science University, Portland, OR","institution_ids":["https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5134831711","display_name":"Jeffrey W Tyner","orcid":"https://orcid.org/0000-0002-2133-0960","observed_orcids":["https://orcid.org/0000-0002-2133-0960"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey W. Tyner","raw_affiliation_strings":["Knight Cancer Institute, Oregon Health & Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Knight Cancer Institute, Oregon Health & Science University, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5125591963","display_name":"Brian J. Druker","orcid":"https://orcid.org/0000-0001-8331-8206","observed_orcids":["https://orcid.org/0000-0001-8331-8206"]},"institutions":[{"id":"https://openalex.org/I1344073410","display_name":"Howard Hughes Medical Institute","ror":"https://ror.org/006w34k90","country_code":"US","type":"facility","lineage":["https://openalex.org/I1344073410"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian J. Druker","raw_affiliation_strings":["Howard Hughes Medical Institute, Portland, OR","Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Howard Hughes Medical Institute, Portland, OR","institution_ids":["https://openalex.org/I1344073410"]},{"raw_affiliation_string":"Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076074507","display_name":"Anupriya Agarwal","orcid":"https://orcid.org/0000-0002-8319-6162","observed_orcids":["https://orcid.org/0000-0002-8319-6162"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I4390039369","display_name":"OHSU Knight Cancer Institute","ror":"https://ror.org/002shna07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anupriya Agarwal","raw_affiliation_strings":["Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR","institution_ids":["https://openalex.org/I165690674","https://openalex.org/I4390039369"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5014545118"],"corresponding_institution_ids":["https://openalex.org/I1344073410","https://openalex.org/I4390039369"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.25223162,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"126","issue":"23","first_page":"3670","last_page":"3670"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.8417999744415283,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.8417999744415283,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.05730000138282776,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.04809999838471413,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/t-cell-acute-lymphoblastic-leukemia","display_name":"T-cell acute lymphoblastic leukemia","score":0.9900000095367432},{"id":"https://openalex.org/keywords/gm-csf-receptor","display_name":"GM-CSF receptor","score":0.7870000004768372},{"id":"https://openalex.org/keywords/ligand-independent-activation","display_name":"ligand-independent receptor activation","score":0.7979999780654907},{"id":"https://openalex.org/keywords/disulfide-bonds","display_name":"disulfide bonds","score":0.7149999737739563},{"id":"https://openalex.org/keywords/receptor-oligomerization","display_name":"receptor oligomerization","score":0.9350000023841858},{"id":"https://openalex.org/keywords/receptor-stability","display_name":"receptor stability","score":0.7179999947547913},{"id":"https://openalex.org/keywords/jak2-stat5-signaling","display_name":"JAK2/STAT5 signaling","score":0.8299999833106995},{"id":"https://openalex.org/keywords/pediatric-leukemia","display_name":"pediatric leukemia","score":0.593999981880188},{"id":"https://openalex.org/keywords/il-5-receptor","display_name":"IL-5 receptor","score":0.4620000123977661},{"id":"https://openalex.org/keywords/il-3-receptor","display_name":"IL-3 receptor","score":0.7670000195503235}],"concepts":[{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5542506575584412},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.5421314239501953},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4981374740600586},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4741498827934265},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.45710310339927673},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.4542525112628937},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.4511793851852417},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4324128031730652},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4315795302391052},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.41590166091918945},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3516436815261841},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.27162986993789673},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.18709993362426758},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.3670.3670","doi":"https://doi.org/10.1182/blood.v126.23.3670.3670","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.3670.3670","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3208110678","https://openalex.org/W2754366885","https://openalex.org/W2342631118","https://openalex.org/W2618282744","https://openalex.org/W2790638576","https://openalex.org/W2742003319","https://openalex.org/W229051577","https://openalex.org/W2070861847","https://openalex.org/W2179484816","https://openalex.org/W1640321573"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Colony":[2],"stimulating":[3],"factor":[4],"2":[5],"receptor":[6,13,23,133,267,313,420,436,512,586],"beta":[7],"(CSF2RB)":[8],"is":[9,136,329,486],"the":[10,26,31,48,105,122,227,245,252,258,274,342,346,354,372,378,384,397,404,498,550,578,581],"shared":[11],"beta-chain":[12],"and":[14,21,39,67,73,131,143,173,189,197,218,276,284,309,315,319,333,364,380,409,438,446,450,504,514,589],"an":[15,146,622,659,683,698,714,731,754,772],"essential":[16],"component":[17],"for":[18,312,324,376,406,497,544,560],"IL-3,":[19],"IL-5":[20],"GM-CSF":[22,29,40],"activation.":[24,518],"In":[25,452],"context":[27],"of":[28,50,124,209,247,291,300,345,357,491,525,531,552,580,625,662,686,701,717,734,757,775],"signaling,":[30],"ligand-specific":[32],"alpha":[33],"chain":[34],"(CSF2RA)":[35],"complexes":[36,290],"with":[37,114,416,488,567],"CSF2RB":[38,51,59,82,165,210,238,307,325,358,385,432,469,507,527,585],"ligand,":[41],"forming":[42],"a":[43,111,170,206,231,248,280,306,330,338,453,502,522,532,557],"dodecameric":[44],"complex":[45,302,587],"in":[46,81,88,98,110,121,153,169,176,205,251,295,341,468,536],"which":[47,485],"proximity":[49],"subunits":[52],"allows":[53],"associated":[54],"JAK2":[55,139,458],"kinases":[56],"to":[57,69,85,138,149,179,183,213,217,236,305,336,411,473,564,576],"trans-phosphorylate.":[58],"signals":[60,482],"through":[61,440,483],"several":[62,360,441,457],"pathways,":[63,442],"including":[64,443],"JAK2/STAT5,":[65],"PI3K/AKT":[66],"MEK/ERK":[68],"promote":[70],"survival,":[71],"proliferation":[72],"differentiation.":[74],"Several":[75],"studies":[76],"have":[77,94,495],"demonstrated":[78,225,496],"that":[79,135,226,257,366,396,427,479,501,541],"mutations":[80,93,152],"can":[83],"lead":[84],"cellular":[86],"transformation":[87],"vitro,":[89],"but":[90],"no":[91],"oncogenic":[92,151],"yet":[95],"been":[96,390],"identified":[97,168,521],"primary":[99,154,506],"leukemia":[100,118],"samples.":[101,164],"Here":[102],"we":[103,156,255,272,352,425,520],"report":[104],"first":[106,499],"such":[107],"mutation,":[108],"found":[109],"pediatric":[112,171],"patient":[113,163],"T-cell":[115],"acute":[116],"lymphoblastic":[117],"(T-ALL),":[119],"resulting":[120],"formation":[123,588],"intermolecular":[125,413,538],"disulfide":[126,339,414,539],"bonds,":[127],"prolonged":[128,232],"protein":[129,211],"half-life,":[130],"ligand-independent":[132,489],"activation":[134,314,490,528],"sensitive":[137],"kinase":[140],"inhibition.":[141],"Methods":[142],"Results":[144],"Through":[145],"ongoing":[147],"effort":[148],"identify":[150],"leukemias,":[155],"performed":[157],"whole-exome":[158],"sequencing":[159],"on":[160,584,621,658,682,697,713,730,753,771],"18":[161],"T-ALL":[162,172],"R461C":[166,187,202,228,253,277,328,433,470,480,575],"was":[167],"stably":[174],"expressed":[175],"Ba/F3":[177,192,220,429],"cells":[178,430,471],"test":[180,270],"its":[181],"capacity":[182],"confer":[184],"factor-independent":[185,510],"growth.":[186],"consistently":[188],"rapidly":[190],"transformed":[191,428],"cells,":[193,554],"while":[194],"wild-type":[195],"(WT)":[196],"vector":[198],"controls":[199],"did":[200],"not.":[201],"expression":[203],"resulted":[204],"substantial":[207],"accumulation":[208],"relative":[212,235,472],"WT,":[214],"both":[215,377],"prior":[216],"following":[219],"transformation.":[221],"Cycloheximide":[222],"time-course":[223],"experiments":[224],"mutant":[229,381],"possessed":[230],"surface":[233,260],"half-life":[234],"WT":[237,275,379,474],"(3.6":[239],"vs.":[240],"6.5":[241],"hours;":[242],"p<0.01).":[243],"Given":[244],"presence":[246],"novel":[249,503,523,537],"cysteine":[250,534],"mutant,":[254],"hypothesized":[256],"increased":[259],"stability":[261],"could":[262,310,542,572],"result":[263],"from":[264],"abnormal,":[265],"disulfide-linked":[266],"oligomerization.":[268],"To":[269,348],"this,":[271],"compared":[273],"receptors":[278],"using":[279,359,561],"non-reducing":[281],"PAGE":[282],"immunoblot":[283,423],"observed":[285],"higher":[286],"molecular":[287],"weight,":[288],"CSF2RB-containing":[289],"500":[292],"KDa":[293],"only":[294],"R461C-expressing":[296],"cells.":[297],"The":[298,317],"size":[299],"this":[301,350],"approximately":[303],"corresponds":[304],"tetramer":[308],"account":[311,543],"accumulation.":[316],"UniProt-listed":[318],"commonly":[320],"used":[321],"transmembrane":[322,355,386,533,582],"domain":[323,356,387,398,583],"(444-460)":[326],"indicates":[327],"cytoplasmic":[331],"residue":[332,367],"therefore":[334],"unlikely":[335],"form":[337,412],"bond":[340],"reducing":[343],"conditions":[344],"cytoplasm.":[347],"resolve":[349],"discrepancy,":[351],"modeled":[353],"advanced":[361],"prediction":[362],"platforms":[363],"concluded":[365],"461":[368,408],"lies":[369],"well":[370],"within":[371],"membrane":[373],"spanning":[374],"region":[375],"receptors.":[382],"While":[383],"has":[388],"not":[389],"empirically":[391],"studied,":[392],"modern":[393],"models":[394],"delineate":[395],"spans":[399],"residues":[400],"443-465,":[401],"thereby":[402,555],"creating":[403],"potential":[405,558],"cysteines":[407],"463":[410],"bonds":[415,540],"homologous":[417],"or":[418,627,664,688,703,719,736,759,777],"heterogeneous":[419],"chains.":[421],"Using":[422],"analysis,":[424],"showed":[426],"expressing":[431],"exhibited":[434],"constitutive":[435,515,526,545],"phosphorylation":[437],"signaled":[439],"STAT-1,":[444],"-3,":[445],"-5,":[447],"AKT/mTOR1,":[448],"MEK/ERK,":[449],"SRC.":[451],"small-molecule":[454],"inhibitor":[455],"screen,":[456],"inhibitors":[459,548,563],"(ruxolitinib,":[460],"tofacitinib,":[461],"AZD1480)":[462],"achieved":[463],"significantly":[464],"lower":[465],"IC50":[466],"concentrations":[467],"(p<0.05).":[475],"These":[476],"results":[477,535],"indicate":[478],"primarily":[481],"JAK2,":[484],"consistent":[487],"CSF2RB.":[492],"Conclusions":[493],"We":[494],"time":[500],"actionable":[505],"mutation":[508],"confers":[509],"growth,":[511],"accumulation,":[513],"JAK/STAT":[516],"pathway":[517],"Furthermore,":[519],"mechanism":[524],"where":[529],"incorporation":[530],"signaling.":[546],"JAK":[547,562],"blocked":[549],"growth":[551],"R461C-transformed":[553],"providing":[556],"rationale":[559],"treat":[565],"patients":[566],"CSF2RB-mutated":[568],"leukemia.":[569],"Future":[570],"research":[571],"also":[573],"utilize":[574],"study":[577],"impact":[579],"recycling.":[590],"Disclosures":[591],"Tyner:":[592],"Aptose":[593],"Biosciences:":[594,748],"Research":[595,599,603,607,610,632,641,667,672,674,724,764,781,785],"Funding;":[596,600,604,608,633,642,668,675,725,765],"Constellation":[597],"Pharmaceuticals:":[598,606,631,640,677],"Array":[601],"Biopharma:":[602],"Janssen":[605],"Incyte:":[609],"Funding.":[611,782,786],"Druker:Aptose":[612],"Therapeutics,":[613],"Inc":[614],"(formerly":[615],"Lorus):":[616],"Consultancy,":[617,678,693,709,728,749,769],"Equity":[618,679,694,710,750],"Ownership,":[619,680,695,711,751],"Membership":[620,657,681,696,712,729,752,770],"entity's":[623,660,684,699,715,732,755,773],"Board":[624,661,685,700,716,733,756,774],"Directors":[626,663,687,702,718,735,758,776],"advisory":[628,665,689,704,720,737,760,778],"committees;":[629,690,705,721,738,761,779],"Novartis":[630],"McGraw":[634],"Hill:":[635],"Patents":[636,644,650,744],"&":[637,645,651,654,741,745],"Royalties;":[638,646,652,746],"Oncotide":[639],"Millipore:":[643],"Henry":[647],"Stewart":[648],"Talks:":[649],"Leukemia":[653],"Lymphoma":[655],"Society:":[656],"committees,":[666],"Fred":[669],"Hutchinson":[670],"Cancer":[671],"Center:":[673],"Cylene":[676],"Blueprint":[691],"Medicines:":[692],"AstraZeneca:":[706],"Consultancy;":[707],"MolecularMD:":[708],"Bristol-Myers":[722],"Squibb:":[723],"Gilead":[726],"Sciences:":[727],"Oregon":[739],"Health":[740],"Science":[742],"University:":[743],"CTI":[747],"Sage":[762],"Bionetworks:":[763],"Roche":[766],"TCRC,":[767],"Inc.:":[768],"ARIAD:":[780],"Agarwal:CTI":[783],"BioPharma:":[784]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-11-30T00:00:00"}